en
Scientific article
English

Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study

Publication date2018
Abstract

Serum phosphate is a key parameter in the management of chronic kidney disease-mineral and bone disorder (CKD-MBD). The timing of phosphate measurement is not standardized in the current guidelines. Since the optimal range of these biomarkers may vary depending on the duration of the interdialytic interval, in this analysis of the Current management of secondary hyperparathyroidism: a multicentre observational study (COSMOS), we assessed the influence of a 2- (midweek) or 3-day (post-weekend) dialysis interval for blood withdrawal on serum levels of CKD-MBD biomarkers and their association with mortality risk.

Citation (ISO format)
FERNÁNDEZ-MARTÍN, José L et al. Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. In: Nephrology, Dialysis, Transplantation, 2018. doi: 10.1093/ndt/gfy093
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0931-0509
344views
0downloads

Technical informations

Creation11/16/2018 8:07:00 AM
First validation11/16/2018 8:07:00 AM
Update time03/15/2023 4:03:27 PM
Status update03/15/2023 4:03:26 PM
Last indexation01/17/2024 5:12:42 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack